Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to Anti-HBs seroconversion in patients with chronic hepatitis B
Marie‐Anne Loriot(Inserm), Jean‐Pierre Benhamou(Université Claude Bernard Lyon 1), Claude Degott, Serge Erlinger(Université Claude Bernard Lyon 1), Nathalie Boyer(Inserm), Patrick Marcellin(Inserm), Michèle Martinot‐Peignoux(Université Claude Bernard Lyon 1), Eric Bismuth(Inserm)
Cited by 110
Related Papers
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
|New England Journal of Medicine|2004|1.1k
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
|Gastroenterology|2006|882
Influence of Human Immunodeficiency Virus Infection on Chronic Hepatitis B in Homosexual Men
|Hepatology|1999|445
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363
Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism
|Clinical Pharmacology & Therapeutics|2006|278